ACRS
Aclaris Therapeutics, Inc. · Healthcare
CFO Kevin Balthaser bought $75K of Aclaris Therapeutics, Inc.
Bought$74,971
$7.90Price
9,490Shares
+159%Stake
What ACRS did for a copier
- $1,000 copied at Thu, Sep 7 close, $7.57
- $703
- S&P 500, same days
- −3.8%
Measured over 30 trading days, to the Oct 19 close.
Kevin Balthaser's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 6. Filed Thu, Sep 7, 12:16 PM ET, during the session. Returns use the Sep 7 close and the Oct 19 close. Not investment advice.